CompletedPhase 3NCT02078024
Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
Studying Onchocerciasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospitals Cleveland Medical Center
- Principal Investigator
- Christopher L King, MD, PhDCase Western Reserve University
- Intervention
- IVM plus ALB(drug)
- Enrollment
- 375 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2014 – 2018
Study locations (1)
- Onchocerciasis Chemotherapy Research Centre, (OCRC) Municipal Hospital, Hohoe, Ghana
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02078024 on ClinicalTrials.govOther trials for Onchocerciasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06350851Development of a New Rapid Diagnostic Test to Support Onchocerciasis EliminationBioaster
- ACTIVE NOT RECRUITINGPHASE2NCT05180461Emodepside Phase II Trial for Treatment of OnchocerciasisDrugs for Neglected Diseases
- ACTIVE NOT RECRUITINGPHASE3NCT03876262Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for OnchocerciasisMedicines Development for Global Health